AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysis.
Saved in:
| Title: | AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysis. |
|---|---|
| Authors: | Ruhwedel, Tristan1 (AUTHOR) tristan.ruhwedel@charite.de, Rogasch, Julian1,2 (AUTHOR), Galler, Markus1 (AUTHOR), Schatka, Imke1 (AUTHOR), Wetz, Christoph1 (AUTHOR), Furth, Christian1 (AUTHOR), Biernath, Nadine3 (AUTHOR), De Santis, Maria3,4 (AUTHOR), Shnayien, Seyd1 (AUTHOR), Kolck, Johannes5 (AUTHOR), Geisel, Dominik5 (AUTHOR), Amthauer, Holger1 (AUTHOR), Beetz, Nick Lasse1,2,5 (AUTHOR) |
| Source: | EJNMMI Research. 8/28/2025, Vol. 15 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
